Application

18063610 · TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES

Filed 2022-12-08 · Abandoned The official file ↗ · Art unit 1641 · Examiner Marianne Dibrino Hard · CPC A61K 9/127 · Selecta Biosciences, Inc. · Selecta BioSciences, Inc.

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

34.0 mo

to disposition 41.6 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.